Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

The funding will be used to support the commercial rollout of Element’s benchtop instrument for ... which is a competitor to Illumina technology, like its mid-range NextSeq 2000 sequencer ...

The NextSeq 550 has been in use since 2018 and is great for mid-range projects such as exome sequencing, whole-transcriptome sequencing, and epigenetic analysis. The NovaSeq X Plus instrument is now ...

Whole transcriptome amplification and tagmentation-based library preparation was performed using the SMART-seq2 protocol, followed by sequencing with 35bp Pair-end using a 75-cycle kit on a NextSeq ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

The spatial solution surpasses industry standards for scale and accuracy, and is compatible with Illumina NextSeq and NovaSeq sequencers, thereby materially reducing the cost of running large-scale ...

Users will go through a chemistry workflow to permeabilize, hybridize, and make a cDNA library that will be fully compatible with illumina sequencers—both NovaSeq and NextSeq. Users can also ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...